Delivery Order SPE2DB22D1017-SPE2DB25FG4AN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,506.70 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The order was competitively awarded as a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,868.41 to AmerisourceBergen Drug Corp for 60-tablet bottles of Eliquis 5 mg, a prescription anticoagulant medication. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on June 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $13,154.40 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This firm fixed-price contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a standard pharmaceutical supply transaction executed under a non-competitive set-aside. The pharmaceutical will be delivered to the place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $11,416.55 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This firm fixed-price delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,100.34 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $4,929.08 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. Issued on August 25, 2025, with an ultimate completion date of August 26, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,629.78 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a prescription anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, utilizing firm fixed-price pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,929.86 for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitively awarded, firm fixed-price contract was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery...
- The Defense Logistics Agency awarded a $9,564.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract was competitively awarded without set-aside provisions and is scheduled for completion by May 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $9,960.98 to AmerisourceBergen Drug Corp for 60-tablet bottles of Eliquis 5 mg, a leading anticoagulant medication. The contract, awarded September 15, 2025, with completion due September 16, 2025, utilizes firm fixed pricing with no small business set-aside. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and brings substantial pharmaceutical distribution capabilities to federal...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG4ANDelivery Order
The Defense Logistics Agency awarded a $37,391.10 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This contract, effective June 2–3, 2025, was competitively awarded without set-aside provisions and carries firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. That prime IDV serves as a comprehensive global pharmaceutical supply vehicle enabling AmerisourceBergen to furnish a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through competitive processes, positioning it as a critical vendor within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.4k | 6/2/25 |